Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority of Zilbrix-Hib vs Tritanrix-HepB/Hiberix in Infants
NCT00473668Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2007
- Primary completion
- Jan 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Zilbrix-Hib in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jun 2007; status: completed.
02
Drugs
Zilbrix-Hib
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00473668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473668.